Close
CDMO Safety Testing 2026
Novotech

Russia to present Sputnik V vaccine against coronavirus at United Nations

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

- Advertisement -

Russia’s permanent mission to the UN and the Health Ministry will hold a presentation, which will provide detailed information on the Russian vaccine against the novel coronavirus disease (COVID-19), mission spokesman Fyodor Strzhizhovsky told Sputnik.

During a speech at the UN General Assembly in September, Russian President Vladimir Putin suggested that the organisation’s employees be provided with the Russian vaccine against coronavirus free of charge. Russia’s Permanent Representative to the UN Vassily Nebenzia, in turn, did not rule out that the vaccine developers would present it at the UN headquarters.

“On Wednesday, December 2, a presentation of the Russian Sputnik V vaccine will take place. Russian Health Minister Mikhail Murashko, Russia’s Permanent Representative to the UN Vassily Nebenzia, and head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriyev will take part in the event,” Strzhizhovsky said.

He said a virtual event entitled “Sputnik V: Vaccine Against COVID-19” will be held on the sidelines of a special session of the UN General Assembly. During the meeting, detailed information on the Russian vaccine will be presented.

In August, Russia’s Health Ministry registered the world’s first vaccine for the prevention of COVID-19, developed by the Gamaleya Research Centre. It was named Sputnik V. The vaccine is based on a well-studied and validated human adenoviral vector platform, the important benefits of which are safety, efficacy and no long-term adverse effects.

>>>

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Bristol Myers Squibb Integrates AI to Advance Manufacturing Quality Systems

Bristol Myers Squibb has entered into a strategic agreement...

QIAGEN and NVIDIA Join Forces to Advance AI-Driven Drug Discovery

QIAGEN's Digital Insights bioinformatics division is set to integrate...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป